The 3D bioprinting market is projected to reach USD 1,647 Million by 2024 from USD 651 Million in 2019, at a CAGR of 20.4% from 2019 to 2024. Increasing investments, funds, and grants by public-private organizations for research; and technological advancements in the market; and rising adoption of 3D bioprinting in the pharmaceutical and cosmetology industries will fuel the market growth over the forecast period.
Drivers
1 Increasing Use of 3D Bioprinting in the Pharmaceutical and Cosmetology Industries
2 Rising Public and Private Funding to Support Bioprinting Research Activities
3 Technological Advancements in the 3D Bioprinting Industry
1 Increasing Use of 3D Bioprinting in the Pharmaceutical and Cosmetology Industries
2 Rising Public and Private Funding to Support Bioprinting Research Activities
3 Technological Advancements in the 3D Bioprinting Industry
Restraints
1 Dearth of Skilled Professionals
2 High Development & Production Costs
3 Lack of Regulatory Guidelines Governing 3D Bioprinting
1 Dearth of Skilled Professionals
2 High Development & Production Costs
3 Lack of Regulatory Guidelines Governing 3D Bioprinting
Download PDF Brochure : https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=170201787
Opportunities
1 Rising Demand for Organ Transplants
2 Growing Awareness of 3D Bioprinting
3 Growing Demand for Regenerative Medicine & Stem Cell Research
1 Rising Demand for Organ Transplants
2 Growing Awareness of 3D Bioprinting
3 Growing Demand for Regenerative Medicine & Stem Cell Research
Challenges
1 Socioethical Concerns Related to the Use of 3D Bioprinted Products
2 High Cost of 3D Bioprinting
3 Process Control & Understanding
1 Socioethical Concerns Related to the Use of 3D Bioprinted Products
2 High Cost of 3D Bioprinting
3 Process Control & Understanding
Comments
Post a Comment